Dr. Lewis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1665 Aurora Ct
Aurora, CO 80045Phone+1 720-848-0300Fax+1 720-848-0526- Is this information wrong?
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2002 - 2004
University of California (Irvine)Residency, Internal Medicine, 1999 - 2002
Albany Medical CollegeClass of 1999
Certifications & Licensure
CA State Medical License 2001 - Present
CO State Medical License 2003 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2011 Jan 18
- Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients Start of enrollment: 2013 Apr 01
- Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) Start of enrollment: 2019 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.Algazi, A., Moon, J., Lao, C., Chmielowski, B., Kendra, K., Lewis, K., Gonzalez, R., Kim, K., Godwin, J., Curti, B., Latkovic-Taber, M., Lomeli, S., Gufford, B., Scump...> ;Cancer. 2024 Jan 23
- 18 citationsOverall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFmutation-positive advanced melanoma (IMspire150): second interim a...Paolo A Ascierto, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov...> ;The Lancet. Oncology. 2023 Jan 1
- 1 citationsEffectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of ...Joseph M Unger, Amy Darke, Megan Othus, Thach-Giao Truong, Nikhil Khushalani, Kari Kendra, Karl D Lewis, Bryan Faller, Pauline Funchain, Elizabeth I Buchbinder, Ahmad ...> ;JAMA Oncology. 2023 Feb 1
- Join now to see all
Press Mentions
Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage CancersMay 26th, 2022- FDA Approves Libtayo for Advanced Basal Cell CarcinomaFebruary 10th, 2021
- FDA Approves Libtayo for Locally Advanced and Metastatic Basal Cell CarcinomaFebruary 10th, 2021
- Join now to see all
Hospital Affiliations
University of Colorado HospitalAurora, Colorado
UCHealth Memorial HospitalColorado Springs, Colorado
UCHealth Poudre Valley HospitalFort Collins, Colorado- University of Colorado Hospital Anschutz Inpatient PavilionAurora, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
